MedPage Today6h
A Good Number of Cancer Patients in Mid-Stage Trials Get Drugs Later Approved
In a sample of 400 phase II trials that included 25,000 participants, a total of 4,045 patients (16.2%) received a treatment ...
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Psychology Today1d
Zyn Nicotine Pouch Products Get FDA Approval for Adults
The FDA approved the sale of Zyn nicotine pouches, which are increasingly popular with teens. But nicotine pouches cause ...
Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
US FDA approves Mirum Pharma's genetic disorder drug
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
dvm3605h
First drug shown to reverse feline HCM expected to receive FDA conditional approval
Expanded conditional approval allows drugs that are undergoing their final clinical trial assessment and are supported by ...
BioPharma Dive1d
Mirum drug for rare genetic disease gains FDA approval
Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendinous xanthomatosis, in a 2023 deal with ...
Medtronic gets FDA approval for Brainsense device in Parkinson's patients
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...